Extended Zerlasiran Data Show Sustained Lp(a) Reduction
The experimental siRNA agent led to prolonged Lp(a) reduction of more than 90%, extended data from the phase 1 trial show, supporting the move to phases 2 and 3 trials.
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The experimental siRNA agent led to prolonged Lp(a) reduction of more than 90%, extended data from the phase 1 trial show, supporting the move to phases 2 and 3 trials.
Semaglutide is an effective treatment option for weight loss, but its cost-effectiveness over the long term compared with ESG needs to be considered.
Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil.
"This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne," the study's senior author Howa Yeung, MD, MSc, said in an interview.
New estimates suggest that more adults with cancer are participating in cancer trial research, especially at National Cancer Institute–designated centers, but overall enrollment rates remain low.